IgM-enriched immunoglobulins in sepsis

Yearbook of Intensive Care and Emergency Medicine 2009

Volumn , Issue , 2007, Pages 102-110

  Esen, F ^a   Tugrul, S ^a  

^a ISTANBUL UNIVERSITY   (Turkey)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 84892062075     PISSN: None     EISSN: None     Source Type: Book    
DOI: 10.1007/978-0-387-92278-2_10     Document Type: Chapter

References (35)

1. Dellinger RP, Carlet JM, Masur H, et al (2004) Surviving Sepsis Campaign Management Guidelines Committee. Surviving Sepsis Campaign guidelines for management of severe sepsis and septic shock. Crit Care Med 32: 858-873
2. Ziegler EJ, McCutchan JA, Fierer J, et al (1982) Treatment of Gram-negative bacteremia and shock with human antiserum to a mutant Escherichia coli. N Engl J Med 307: 1225-1230
3. Alejandria MM, Lansang MA, Dans LF, Mantaring JB (2002) Intravenous immunoglobulin for treating sepsis and septic shock. Cochrane Database Syst Rev CD0011090
4. Kreymann KG, de Heer G, Nierhaus A, Kluge S (2007) Use of polyclonal immunoglobulins as adjunctive therapy for sepsis or septic shock. Crit Care Med 35: 2677-2685
5. Norrby-Teglund A, Haque KN, Hammarström L (2006) Intravenous polyclonal IgM-enriched immunoglobulin therapy in sepsis: a review of clinical efficacy in relation to microbiological aetiology and severity of sepsis. J Intern Med 260: 509-516
6. Laupland KB, Kirkpatrick AW, Delaney A (2007) Polyclonal intravenous immunoglobulin for the treatment of severe sepsis and septic shock in critically ill adults: a systematic review and meta-analysis. Crit Care Med 35: 2686-2692
7. Pildal J, Gøtzsche PC(2004) Polyclonal immunoglobulin for treatment of bacterial sepsis: a systematic review. Clin Infect Dis 39: 38-46
8. Turgeon AF, Hutton B, Fergusson DA, et al (2007) Meta-analysis: intravenous immunoglobulin in critically ill adult patients with sepsis. Ann Intern Med 146: 193-203
9. Werdan K, Pilz G, Bujdoso O, et al (2007) Score-based immunoglobulin G therapy of patients with sepsis: the SBITS study. Crit Care Med 35: 2693-2701
10. Negi VS, Elluru S, Sibéril S, et al (2007) Intravenous immunoglobulin: an update on the clinical use and mechanisms of action. J Clin Immunol 27: 233-245
11. Werdan K (2001) Intravenous immunoglobulin for prophylaxis and therapy of sepsis. Curr Opin Crit Care 7: 354-361
12. Stephan W (1989) Investigations to demonstrate the antibacterial and antitoxic efficacy of an IgM-Enriched intravenous immunoglobulin preparation. In: Faist E, Ninnemann J, Green D (eds) Immune Consequences of Trauma; Shock and Sepsis. Springer-Verlag, Heidelberg, pp 501-507
13. Stephan W, Dichtelmüller H, Schedel I (1985) [Properties and efficacy of a human immunoglobulin M preparation for intravenous administration]. Arzneimittelforschung 35: 933-936
14. Garbett ND, Matharu GS, Cole PJ (1989) Defective opsonization of Haemophilus influenzae by sera of elderly patients. Clin Exp Immunol 76: 73-75
15. Rieben R, Roos A, Muizert Y, Tinguely C, Gerritsen AF, Daha MR (1999) Immunoglobulin Menriched human intravenous immunoglobulin prevents complement activation in vitro an in vivo in a rat model of acute inflammation. Blood 93: 942-951
16. Trautmann M, Held TK, Susa M, et al (1998) Bacterial lipopolysaccharide (LPS)-specific antibodies in commercial human immunoglobulin preparations: superior antibody content of an IgM-enriched product. Clin Exp Immunol 111: 81-90
17. Berger D, Schleich S, Seidelmann M, Berger HG (1993) Antiendotoxic therapy with polyclonal and polyvalent immunoglobulins: in vitro an in vivo studies. In: Faist E Meakins JL, Schildberg FW (eds) Host Defense Dysfunction in Trauma, Shock and Sepsis. Springer-Verlag, Heidelberg, pp 1164-1174
18. Norrby-Teglund A, Ihendyane N, Kansal R, et al (2000) Relative neutralizing activity in polyspecific IgM, IgA, and IgG preparations against group A streptococcal superantigens. Clin Infect Dis 31: 1175-1182
19. Oesser S, Schulze C, Seifert J (1999) Protective capacity of an IgM/IgA-enriched polyclonal immunoglobulin-G preparation in endotoxemia. Res Exp Med 198: 325-339
20. Jacobs S, Sobki S, Morais C, Tariq M. (2000) Effect of pentaglobin and piperacillin on survival in a rat model of faecal peritonitis: importance of intervention timings. Acta Anaesthesiol Scand 44: 88-95
21. Hoffman JN, Fertmann JM, Vollmar B, Laschke MW, Jauch KW, Menger MD (2008) Immunoglobulin M-enriched human intravenous immunoglobulins reduce leukocyte-endothelial cell interactions and attenuate microvascular perfusion failure in normotensive endotoxemia. Shock 29: 133-139
22. Stehr SN, Knels L, Weissflog C, et al (2008) Effects of IGM-enriched solution on polymorphonuclear neutrophil function, bacterial clearance, and lung histology in endotoxemia. Shock 29: 167-172
23. Lachmann RA, van Kaam AH, Haitsma JJ, Verbrugge SJ, Delreu F, Lachmann B (2004) Immunoglobulin M-enriched intravenous polyclonal immunoglobulins reduce bacteremia following Klebsiella pneumoniae infection in an acute respiratory distress syndrome rat model. Exp Lung Res 30: 251-260
24. Schedel I, Dreikhausen U, Nentwig B, et al (1991) Treatment of gram-negative septic shock with an immunoglobulin preparation: A prospective, randomized clinical trial. Crit Care Med 19: 1104-1113
25. Tugrul S, Ozcan PE, Akinci O, et al (2002) The effects of IgM-enriched immunoglobulin preparations in patients with severe sepsis. Crit Care 6: 357-362
26. Karatzas S, Boutzouka E, Venetsanou K, Myrianthefs P, Fildisis G, Baltopoulos G (2002) The effects of IgM-enriched immunoglobulin preparations in patients with severe sepsis: another point of view. Crit Care 6: 543-544
27. Rodŕiguez A, Rello J, Neira J, et al (2005) Effects of high-dose of intravenous immunoglobulin and antibiotics on survival for severe sepsis undergoing surgery. Shock 23: 298-304
28. Hentrich M, Fehnle K, Ostermann H, et al (2006) IgMA-enriched immunoglobulin in neutropenic patients with sepsis syndrome and septic shock: a randomized, controlled, multiplecenter trial. Crit Care Med 34: 1319-1325
29. Werdan K, Pilz G, Müller-Werdan U, et al (2008) Immunoglobulin G treatment of postcardiac surgery patients with score-identified severe systemic inflammatory response syndrome - the ESSICS study. Crit Care Med 36: 716-723
30. Pilz G, Kreuzer E, Kaab S, Appel R, Werdan K (1994) Early sepsis treatment with immunoglobulins after cardiac surgery in score-identified high-risk patients. Chest 105: 76-82
31. Pilz G, Appel R, Kreuzer E, Werdan K (1997) Comparison of early IgM-enriched immunoglobulin vs polyvalent IgG administration in score-identified postcardiac surgical patients at high risk for sepsis. Chest 111: 419-426
32. Buda S, Riefolo A, Biscione R, et al (2005) Clinical experience with polyclonal IgM-enriched Immunoglobulins in a group of patients affected by sepsis after cardiac surgery. J Cardiothorac Vasc Anesth 19: 440-445
33. Kress HG, Scheidewing C, Schmidt H, Silber R (1999) Reduced incidence of postoperative infection after intravenous administration of an immunoglobulin A- and immunoglobulin M-enriched preparation in anergic patients undergoing cardiac surgery. Crit Care Med 27: 1281-1287
34. Haque K, Remo C, Bahakim H (1995) Comparison of two types of intravenous immunoglobulins in the treatment of neonatal sepsis. Clin Exp Immunol 101: 328-333
35. Mohr M, Englisch L, Roth A, Burchardi H, Zielmann S (1997) Effects of early treatment with immunoglobulin on critical illness polyneuropathy following multiple organ failure and gram-negative sepsis. Intensive Care Med 23: 1144-1149